NO995620L - Antivirale kombinasjoner inneholdende karbocyklisk nukleosid 1592U89 - Google Patents

Antivirale kombinasjoner inneholdende karbocyklisk nukleosid 1592U89

Info

Publication number
NO995620L
NO995620L NO995620A NO995620A NO995620L NO 995620 L NO995620 L NO 995620L NO 995620 A NO995620 A NO 995620A NO 995620 A NO995620 A NO 995620A NO 995620 L NO995620 L NO 995620L
Authority
NO
Norway
Prior art keywords
combinations containing
carbocyclic nucleoside
containing carbocyclic
antiviral combinations
antiviral
Prior art date
Application number
NO995620A
Other languages
English (en)
Norwegian (no)
Other versions
NO995620D0 (no
Inventor
David Walter Barry
Clair Martha Heider St
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9709945.1A external-priority patent/GB9709945D0/en
Priority claimed from GBGB9719883.2A external-priority patent/GB9719883D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO995620D0 publication Critical patent/NO995620D0/no
Publication of NO995620L publication Critical patent/NO995620L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO995620A 1997-05-17 1999-11-16 Antivirale kombinasjoner inneholdende karbocyklisk nukleosid 1592U89 NO995620L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9709945.1A GB9709945D0 (en) 1997-05-17 1997-05-17 A novel salt
GBGB9719883.2A GB9719883D0 (en) 1997-09-19 1997-09-19 Antiviral combinations
PCT/EP1998/002836 WO1998052570A1 (en) 1997-05-17 1998-05-14 Antiviral combinations containing the carbocyclic nucleoside 1592u89

Publications (2)

Publication Number Publication Date
NO995620D0 NO995620D0 (no) 1999-11-16
NO995620L true NO995620L (no) 2000-01-14

Family

ID=26311543

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995620A NO995620L (no) 1997-05-17 1999-11-16 Antivirale kombinasjoner inneholdende karbocyklisk nukleosid 1592U89

Country Status (12)

Country Link
EP (1) EP0979082A1 (es)
JP (1) JP2001525839A (es)
AR (1) AR012702A1 (es)
AU (1) AU7912398A (es)
BR (1) BR9809127A (es)
CA (1) CA2289655A1 (es)
CO (1) CO4950569A1 (es)
HR (1) HRP980264A2 (es)
MA (1) MA26496A1 (es)
NO (1) NO995620L (es)
PE (1) PE74799A1 (es)
WO (1) WO1998052570A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP990030A2 (en) * 1998-02-17 1999-10-31 Michael B. Maurin Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
US20010014352A1 (en) 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
EP1332757B1 (en) * 1998-05-27 2012-06-13 Merck Sharp & Dohme Corp. Efavirenz compressed tablet formulation
PE20000559A1 (es) * 1998-05-27 2000-07-05 Merck & Co Inc Formulacion de tabletas comprimidas de efavirenz
WO2013111147A1 (en) * 2011-12-19 2013-08-01 Hetero Research Foundation Extended release compositions of nevirapine
JP6391561B2 (ja) * 2013-02-27 2018-09-19 国立大学法人京都大学 がんの予防または治療用医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417249D0 (en) * 1994-08-26 1994-10-19 Wellcome Found A novel salt
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc

Also Published As

Publication number Publication date
EP0979082A1 (en) 2000-02-16
JP2001525839A (ja) 2001-12-11
PE74799A1 (es) 1999-08-13
NO995620D0 (no) 1999-11-16
WO1998052570A1 (en) 1998-11-26
AU7912398A (en) 1998-12-11
HRP980264A2 (en) 1999-02-28
AR012702A1 (es) 2000-11-08
CA2289655A1 (en) 1998-11-26
BR9809127A (pt) 2000-08-01
CO4950569A1 (es) 2000-09-01
MA26496A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
DK0574457T3 (da) Antiviral nucleosidkombination
HUP9801571A2 (hu) Zidovudin, 1592U89 és 3TC vagy FTC szinergetikus kombinációi
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
NO20053817L (no) Preparater og fremgangsmater for antiviral kombinasjonsterapi.
FR16C0028I2 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
MX9204454A (es) Derivados de tiourea para inhibir la replicacion del virus de inmunodeficiencia humana y formulado farmaceutico que los contiene.
BRPI0313664B8 (pt) compostos inibidores de nucleosídeo fosforilase e nucleosidases, suas composições e seus usos
DK1469843T3 (da) Komposition til farmaceutisk eller diætetisk anvendelse til at bekæmpe hårtab
NO942303L (es)
DK0777669T3 (da) 4-[2-amino-6-(cyclopropylamino)-9H-purin-yl]-2-cyclopenten-1-methanolsuccinat som antiviralt middel
NO986034L (no) Kombinasjoner omfattende VX 478, ZidovudÞn, FTC og/eller 3TC for anvendelse i behandling av HIV
BG103959A (en) Carbocyclic nucleoside hemisulphate and its application in the treatment of viral infections
IE893991L (en) 2',3'-dideoxypurine nucleoside/purine nucleoside¹phosphorylase inhibitor combination therapy and composition
DE50212933D1 (de) Die verwendung von pyrimidinnukleosiden und/oder prodrugs davon zur bekämpfung von nebenwirkungen der "haart" (highly active anti-retroviral therapy) und anderen antiviralen therapien
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
NO995621L (no) Antivirale kombinasjoner inneholdende karbocyklisk nukleoid 1592U89
BR9809127A (pt) Combinação, formulação farmacêutica, processo para o tratamento de uma infecção por hiv em um animal infectado, uso de (-) -(1s,4r)-4-[2-amino-6-(ciclopropil amino)-9h-purin-9-il)-2-ciclopenteno-1-metanol, e, pacote de paciente
TR199801439T2 (xx) Herpes simpleks enfeksiyonlar�n�n kombine terapisinde n�kleosit analoglar�.
NO986035L (no) Kombinasjoner omfattende VX478, zidovudin og/eller 1592U89 for anvendelse i behandling av HIV
NO991589L (no) Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler
MXPA04004061A (es) Derivados de quinolina y piridina antiretrovirales.
WO2002092062A3 (en) Combination of vitamin d analogue and pyrimidine nucleoside analogue
PT1411956E (pt) Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih
DK0685235T3 (da) Ekstrakter af Piliostigma thonningii, anvendelse heraf og formuleringer, som indeholder dem
KR920019362A (ko) 디데옥시 아데노신 및 아데노신 데아미나제 억제물질을 포함하는, 항-hiv활성을 지닌 치료학적 조성물

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application